🟢 AIDX is trading 5.9% up today after its acquisition-heavy growth plan webinar

AIDX is trading 5.9% up now at $0.65 as investors react to its July 1 investor webinar outlining an aggressive buy‑and‑build acquisition strategy and scaling of its cancer‑screening blood test toward Medicare reimbursement.[6a461fcce1083a6e1bebc5fc] The stock had initially fallen 9.6% to $0.55 when the plan was first presented, but the subsequent rebound suggests traders are reassessing the growth potential despite skepticism about executing such a strategy with a $6 million market cap.[6a461fcce1083a6e1bebc5fc]